Shopping Cart
- Remove All
- Your shopping cart is currently empty
Methysticin, a major kavalactone extracted from kava, can induce CYP1A1.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $698 | Backorder |
Description | Methysticin, a major kavalactone extracted from kava, can induce CYP1A1. |
In vivo | Methysticin (6 mg/kg) is administered orally once weekly for six months to 6-month-old transgenic APP/Psen1 mice. This treatment initiates activation of the Nrf2 pathway in the mice's hippocampus and cortex. Despite Methysticin not altering Aβ deposition in the brains of treated APP/Psen1 mice compared to controls, it significantly mitigates microgliosis, astrogliosis, and the secretion of pro-inflammatory cytokines TNF-α and IL-17A. Additionally, Methysticin markedly activates the Nrf2/ARE pathway specifically in the hippocampus and cortex, but not in the midbrain and cerebellum of ARE-luciferase reporter gene mice, leading to a significant increase in the expression of both genes relative to untreated animals. |
Alias | DL-Methysticin, (±)-Methystici |
Molecular Weight | 274.27 |
Formula | C15H14O5 |
Cas No. | 20697-20-5 |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | Ethanol: 1 mg/mL (3.65 mM) DMSO: 5 mg/mL (18.23 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.